Aspen Aerogels (NYSE:ASPN) Sets New 12-Month Low Following Analyst Downgrade

Shares of Aspen Aerogels, Inc. (NYSE:ASPNGet Free Report) hit a new 52-week low during mid-day trading on Thursday after B. Riley lowered their price target on the stock from $35.00 to $22.00. B. Riley currently has a buy rating on the stock. Aspen Aerogels traded as low as $8.25 and last traded at $8.27, with a volume of 94029 shares trading hands. The stock had previously closed at $8.30.

Other equities research analysts have also recently issued reports about the company. Canaccord Genuity Group cut their price target on Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating for the company in a research note on Friday, February 14th. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a research note on Wednesday. Craig Hallum lowered their price objective on shares of Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating for the company in a research report on Friday, February 14th. Roth Mkm lowered their price objective on shares of Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating for the company in a research report on Friday, February 14th. Finally, Seaport Res Ptn downgraded shares of Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, February 12th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $22.44.

Get Our Latest Stock Report on ASPN

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Quest Partners LLC increased its holdings in shares of Aspen Aerogels by 263.3% during the third quarter. Quest Partners LLC now owns 7,397 shares of the construction company’s stock worth $205,000 after buying an additional 5,361 shares in the last quarter. Sandia Investment Management LP acquired a new position in shares of Aspen Aerogels during the fourth quarter worth $89,000. Pursue Wealth Partners LLC acquired a new position in shares of Aspen Aerogels during the third quarter worth $222,000. Mesirow Financial Investment Management Inc. acquired a new position in shares of Aspen Aerogels during the third quarter worth $252,000. Finally, Kovitz Investment Group Partners LLC acquired a new position in shares of Aspen Aerogels during the third quarter worth $263,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Aspen Aerogels Trading Down 1.4 %

The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The company has a market cap of $659.27 million, a P/E ratio of 50.22 and a beta of 2.14. The firm’s 50 day moving average is $11.75 and its two-hundred day moving average is $18.15.

Aspen Aerogels (NYSE:ASPNGet Free Report) last issued its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. As a group, equities research analysts anticipate that Aspen Aerogels, Inc. will post 0.22 EPS for the current year.

Aspen Aerogels Company Profile

(Get Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Recommended Stories

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.